PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2014 | 4 | 3 | A108-112
Article title

Percutaneous vena cava superior angioplasty and stenting as an effective method of treatment in vena cava superior syndrome in the course of lung cancer

Content
Title variants
Languages of publication
EN
Abstracts
EN
Vena cava superior syndrome (VCSS) is a sudden life-threatening condition encountered in patients with neoplasms. The prognosis depends on histopathological diagnosis, severity of clinical symptoms and administered treatment. Depending on the type of neoplasm, the treatment of choice may be radiotherapy or chemotherapy. In patients with rapidly increasing clinical symptoms the justified management is percutaneous balloon angioplasty of the superior vena cava with the placement of stents.
Discipline
Publisher

Journal
Year
Volume
4
Issue
3
Pages
A108-112
Physical description
Contributors
  • Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, European Health Centre Otwock, Poland, szymon.darocha@gmail.com
  • Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, European Health Centre Otwock, Poland
  • Department of Radiography, Medical University of Lublin, Poland
  • Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, European Health Centre Otwock, Poland
References
  • Escalante CP. Causes and management of superior vena cava syndrome. Oncology 1993; 7: 61-8.
  • Ganeshan A, Hon LQ, Warakaulle DR et al. Superior vena caval stenting for SVC obstruction: current status. Eur J Radiol 2009; 71(2): 343-9.
  • Kowalski DM, Krzakowski M. Zespół żyły głównej górnej – rozpoznawanie i leczenie. In: Postępowanie w powikłaniach sercowo-naczyniowych w raku płuca. Rekomendacje Krajowego Nadzoru Kardiologicznego i Onkologicznego dotyczące bezpieczeństwa kardiologicznego u chorych na raka płuca. Krzakowski M, Opolski G, Szmit S (ed.). Medical Education, Warszawa 2012: 21-29.
  • You JB, Wilson LD, Detterbeck FC. Superior vena cava syndrome – a proposed classification system and algorithm for management. J Thorac Oncol 2008; 3: 811-814.
  • Wilson LD, Detterbeck FC, Yahalom J. Superior vena cava syndrome with malignant causes. N Engl J Med 2007; 356: 1862-1869.
  • Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Syst Rev 2001(4): CD001316.
  • Sobrinho G, Aguiar P. Stent placement for the treatment of malignant superior vena cava syndrome – a single-center series of 56 patients. Arch Bronconeumol 2014; 50(4): 135-40.
Document Type
report
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-436c6be3-f07c-4aa2-a2c7-ae79659f215c
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.